Colgate-Palmolive Company (NYSE:CL) Shares Sold by Mizuho Markets Americas LLC

Key Points

• Mizuho Markets Americas LLC reduced its holdings in Colgate-Palmolive by 47.1% in the first quarter, selling 12,713 shares, which left them with a total of 14,298 shares valued at approximately $1.34 million.
• Colgate-Palmolive's recent earnings report showed an Earnings Per Share (EPS) of $0.92, exceeding analysts' expectations of $0.89, with revenue reaching $5.11 billion for the quarter.
• The company declared a quarterly dividend of $0.52 per share, which will be paid on August 15, representing an annualized yield of 2.5%.

Mizuho Markets Americas LLC decreased its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 47.1% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 14,298 shares of the company's stock after selling 12,713 shares during the period. Mizuho Markets Americas LLC's holdings in Colgate-Palmolive were worth $1,340,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Personal CFO Solutions LLC purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at $285,000. Vision Capital Management Inc. purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at $322,000. Autumn Glory Partners LLC lifted its position in shares of Colgate-Palmolive by 67.4% in the first quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after acquiring an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. purchased a new stake in shares of Colgate-Palmolive in the first quarter valued at $2,166,000. Finally, Summit Investment Advisors Inc. lifted its position in shares of Colgate-Palmolive by 10.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 32,710 shares of the company's stock valued at $2,974,000 after acquiring an additional 3,187 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 2.0%

Shares of CL stock traded down $1.69 during trading hours on Thursday, reaching $84.65. The company had a trading volume of 1,519,544 shares, compared to its average volume of 5,232,065. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive Company has a twelve month low of $82.40 and a twelve month high of $109.30. The company has a market capitalization of $68.42 billion, a P/E ratio of 23.78, a price-to-earnings-growth ratio of 4.42 and a beta of 0.35. The stock's fifty day simple moving average is $88.41 and its 200 day simple moving average is $90.07.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. The business had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter last year, the firm earned $0.91 earnings per share. The company's revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is 58.43%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CL. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Barclays increased their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Citigroup reduced their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. Morgan Stanley reduced their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Finally, Wells Fargo & Company reduced their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, August 4th. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.